{"nct_id":"NCT03833180","title":"A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)","status":"COMPLETED","status_verified_date":"2024-01","start_date":"2019-03-14","start_date_type":"ACTUAL","primary_completion_date":"2023-12-18","primary_completion_date_type":"ACTUAL","completion_date":"2023-12-18","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}